REVB logo

Revelation Biosciences (REVB)

Profile

Full Name

Revelation Biosciences, Inc.

Ticker Symbol

REVB

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

November 17, 2020

Indexes

Not included

Website

http://www.revbiosciences.com

Employees

8

Key Details

Price

$3.08(+2.67%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$87.68(-938.86% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$3.08
REVB price is $3.08

30-Day Relative Volume

0.06
REVB 30-day relative volume is 0.06

Price Performance

Price Most recent change

+2.67%
REVB price was up +2.67% on Apr 17, 2025

Price YTD change

-58.24%
REVB price is down -58.24% since January 1st

Price 1-year change

-91.05%
REVB price is down -91.05% year-on-year

Price 3-year change

-99.98%
REVB price is down -99.98% over the past 3 years

Price Range

Price All-time high

$177240.00
REVB price is currently -100.00% below its historical high of $177240.00

Price 3-year low

$0.28
REVB price is currently +996.09% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$2.79M
REVB market capitalization is $2.79 million

Market cap 3-year change

-80.59%
REVB market capitalization is down -80.59% over the past 3 years

Market cap All-time high

$124.32M
REVB market capitalization is currently -97.76% below its historical high of $124.32 million

Market cap sector rank

8.15%
REVB market capitalization is higher than 8.15% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+786.58%
REVB shares outstanding is up +786.58% year-on-year

Shares Outstanding 3-Year Change

+100477.78%
REVB shares outstanding is up +100477.78% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.47
REVB beta is 0.47

200-day SMA

$11.42
REVB price is currently -73.02% below its 200-day simple moving average

50-day SMA

$3.40
REVB price is currently -9.33% below its 50-day simple moving average

RSI

48.52
REVB 14-day relative strength index is 48.52

Volume

0.06
REVB 30-day relative volume is 0.06

ATR

$0.36
REVB average true range is $0.36

10-day Historical Volatility

224.46%
REVB 10-day historical volatility is 224.46%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
REVB annual revenue value is unknown

Revenue Analysts estimate

-
REVB annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
REVB annual revenue 1-year change is unknown

Revenue Sector rank

-
REVB annual revenue is unknown

EPS

EPS

-$87.68
REVB annual earnings per share is -$87.68

EPS Analysts estimate

-$21.70
REVB annual earnings per share is currently +303.96% higher than the consensus analysts' forecast

EPS 1-year change

-938.86%
REVB annual earnings per share is down -938.86% year-on-year

EPS Sector rank

2.4%
REVB annual earnings per share is higher than 2.4% of companies in Healthcare sector

Profit

Gross profit

-
REVB annual gross profit value is unknown

Gross margin

-
REVB annual gross profit margin value is unknown

Operating profit

-$7.98M
REVB annual operating income is -$7.98 million

Operating margin

-
REVB annual operating profit margin value is unknown

Net income

-$15.04M
REVB annual net profit is -$15.04 million

Net margin

-
REVB annual net profit margin value is unknown

Expenses

Total expenses

$7.98M
REVB annual total expenses is $7.98 million

Operating expenses

$7.98M
REVB annual total operating expenses is $7.98 million

Cost of goods sold

-
REVB annual cost of goods sold value is unknown

Selling, general & administrative expenses

$4.43M
REVB annual SGA is $4.43 million

Depreciation and amortization

$27.90K
REVB annual depreciation & amortization is $27.90 thousand

Interest expense

-
REVB annual interest expense value is unknown

Income tax

-
REVB annual income tax value is unknown

EBIT & EBITDA

EBIT

-$7.98M
REVB annual earnings before interest & taxes is -$7.98 million

EBITDA

-$7.95M
REVB annual EBITDA is -$7.95 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$6.62M
REVB annual total assets is $6.62 million

Non current assets

$56.30K
REVB annual long term assets is $56.30 thousand

Current assets

$6.57M
REVB annual total current assets is $6.57 million

Cash and cash equivalents

$6.50M
REVB annual cash & cash equivalents is $6.50 million

Accounts receivable

-
REVB annual accounts receivable value is unknown

Inventory

-
REVB annual inventory value is unknown

Liabilities

Total liabilities

$1.91M
REVB annual total liabilities is $1.91 million

Long term liabilities

$0.00
REVB annual total long term liabilities is $0.00

Current liabilities

$1.91M
REVB annual total current liabilities is $1.91 million

Accounts payable

$783.60K
REVB annual accounts payable is $783.60 thousand

Debt

Total debt

$0.00
REVB annual total debt is $0.00

Total debt 1-year change

0%
REVB {parameterFullLabel} has remained unchanged year-on-year

Long term debt

-
REVB annual long term debt value is unknown

Short term debt

-
REVB annual short term debt value is unknown

Equity & Capital

Shareholders equity

$4.71M
REVB annual stockholders equity is $4.71 million

Book value

$4.71M
REVB annual book value is $4.71 million

Retained earnings

-$40.51M
REVB annual retained earnings is -$40.51 million

Working capital

$4.65M
REVB annual working capital is $4.65 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$18.32M
REVB annual cash flow from operations is -$18.32 million

Cash from operations 1-year change

-151.45%
REVB annual cash flow from operations is down -151.45% year-on-year

Cash from investing

-$19.20K
REVB annual cash flow from investing activities is -$19.20 thousand

Cash from investing 1-year change

-100%
REVB annual cash flow from investing activities is down -100% year-on-year

Cash from financing

$12.85M
REVB annual cash flow from financing activities is $12.85 million

Cash from financing 1-year change

-8.39%
REVB annual cash flow from financing activities is down -8.39% year-on-year

CAPEX

CAPEX

-
REVB annual capital expenditures value is unknown

CAPEX 1-year change

-
REVB annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$18.34M
REVB annual free cash flow is -$18.34 million

Free cash flow 1-year change

-151.71%
REVB annual free cash flow is down -151.71% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
REVB annual gross profit margin value is unknown

Operating margin

-
REVB annual operating profit margin value is unknown

Net margin

-
REVB annual net profit margin value is unknown

ROA & ROE

ROA

-227.10%
REVB annual return on assets is -227.10%

ROE

-319.40%
REVB annual return on equity is -319.40%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
REVB price to earnings ratio value is unknown

PE ratio Sector rank

-
REVB price to earnings ratio is unknown

PB Ratio

PB ratio

0.59
REVB price to book ratio is 0.59

PB ratio Sector rank

32.32%
REVB price to book ratio is higher than 32.32% of companies in Healthcare sector

PS Ratio

PS ratio

-
REVB price to sales ratio value is unknown

PS ratio Sector rank

-
REVB price to sales ratio is unknown

Enterprise value

Enterprise value

-$3.71M
REVB enterprise value is -$3.71 million

Enterprise value Sector rank

7.11%
REVB enterprise value is higher than 7.11% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.47
REVB EV/EBITDA is 0.47

EV/EBITDA Sector rank

72.32%
REVB EV/EBITDA is higher than 72.32% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.43
REVB annual current ratio is 3.43

Quick ratio

-
REVB annual quick ratio value is unknown

Leverage

Debt to equity

0.00
REVB annual debt to equity ratio is 0.00

Interest coverage ratio

-
REVB annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
REVB piotroski f-score value is unknown

Altman Z-Score

-
REVB altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Feb 14, 23 Roth MKM
Buy
Feb 17, 22 Roth Capital
Buy

Institutional Ownership

Similar stocks

SNPX logo
Synaptogenix (SNPX)
ONVO logo
Organovo Holdings (ONVO)
ICCT logo
iCoreConnect (ICCT)
TTOO logo
T2 Biosystems (TTOO)
Catheter Precision (VTAK)
ADTX logo
Aditxt (ADTX)
EIGR logo
Eiger BioPharmaceuticals (EIGR)
LIXT logo
Lixte Biotechnology Holdings (LIXT)
OMGA logo
Omega Therapeutics (OMGA)
  • What is the ticker symbol for Revelation Biosciences?
  • Does Revelation Biosciences pay dividends?
  • What sector is Revelation Biosciences in?
  • What industry is Revelation Biosciences in?
  • What country is Revelation Biosciences based in?
  • When did Revelation Biosciences go public?
  • Is Revelation Biosciences in the S&P 500?
  • Is Revelation Biosciences in the NASDAQ 100?
  • Is Revelation Biosciences in the Dow Jones?
  • When does Revelation Biosciences report earnings?
  • Should I buy Revelation Biosciences stock now?

What is the ticker symbol for Revelation Biosciences?

The ticker symbol for Revelation Biosciences is NASDAQ:REVB

Does Revelation Biosciences pay dividends?

No, Revelation Biosciences does not pay dividends

What sector is Revelation Biosciences in?

Revelation Biosciences is in the Healthcare sector

What industry is Revelation Biosciences in?

Revelation Biosciences is in the Biotechnology industry

What country is Revelation Biosciences based in?

Revelation Biosciences is headquartered in United States

When did Revelation Biosciences go public?

Revelation Biosciences's initial public offering (IPO) was on November 17, 2020

Is Revelation Biosciences in the S&P 500?

No, Revelation Biosciences is not included in the S&P 500 index

Is Revelation Biosciences in the NASDAQ 100?

No, Revelation Biosciences is not included in the NASDAQ 100 index

Is Revelation Biosciences in the Dow Jones?

No, Revelation Biosciences is not included in the Dow Jones index

When does Revelation Biosciences report earnings?

The date for Revelation Biosciences's next earnings report has not been announced yet

Should I buy Revelation Biosciences stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page